Accure Therapeutics is a startup founded in 2017. Brouky records 1 investor associated with the company.
Accure Therapeutics is an R&D pharmaceutical company developing medicines to treat central nervous system (CNS) disorders, focusing on neurodegeneration and neuroinflammation. The company is advancing clinical candidates (e.g., ACT-03) for indications such as Parkinson’s disease and post-traumatic epilepsy and has received public and foundation grants to support development.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.